Sarah Siber
Partner at Oberland Capital
New York City, New York
Sarah Siber, Partner at Oberland Capital is an active investor based in New York City, New York. This profile covers what Sarah Siber backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCVenture Debt
- Stages
- SeedSeries ASeries BLate Stage Venture
- Invests in
- Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseIoT & Connected DevicesFoodTech & AgricultureFood & Beverage
- Location
- New York City, New York
- Typical check
- $2M
- Past investments
- 4
Notable investments
Mirum Pharmaceuticals
Impact Biomedicines
NorthStar Medical Radioisotopes
Primmune TherapeuticsHow to reach Sarah Siber
Angels and operators like Sarah Siber reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Sarah Siber
Frequently Asked Questions
What does Sarah Siber invest in?
Sarah Siber invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Seed, Series A, Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Sarah Siber invest at?
Sarah Siber typically invests at Seed, Series A, Series B and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Sarah Siber's typical check size?
Sarah Siber typically writes checks around $2M. Use it as a signal for whether your raise fits their stage.
How do I contact Sarah Siber?
Unlock Sarah Siber's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.